Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Large Cap Core AlphaDEX UCITS ETF 26.03.2026 FEX.LN IE00B8X9NW27 1,058,271.00 USD 106,696,683.55 100.822  ...

BRUXELLES--(BUSINESS WIRE)--Regulatory News: Le Groupe TITAN (Brussels:TITC) a publié son Rapport annuel intégré (RAI) 2025, présentant les résultats du Groupe, la mise en œuvre de sa stratégie, sa gouvernance, les avancées en matière de durabilité et de transformation numérique, ainsi que les principales réalisations pour l’exercice clos le 31 décembre 2025. 2025 a constitué une année charnière pour le Groupe TITAN, marquée par une transformation accélérée, une performance financière record et...

BRUSSELS--(BUSINESS WIRE)--Regulatory News: TITAN Group (Brussels:TITC) has published its 2025 Integrated Annual Report (IAR), presenting the company’s results, strategy execution, governance, sustainability and digitalization progress, and key achievements for the year ended 31 December 2025. 2025 was a landmark year for ΤΙΤΑΝ -one of accelerated transformation, record financial performance, and bold strategic moves. The Group signed three cement acquisitions, completed several aggregates bolt...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share FIRST TRUST BLOOMBERG GLOBAL SEMICONDUCTOR SUPPLY CHAIN UCITS ETF 26.03.2026 CHPS.LN IE000KXTLDE2 700,002.00 USD 24,041,057.77 34.344  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx Global Aerospace & Defence UCITS ETF 26.03.2026 MISL.LN IE000NVDQXE1 3,650,002.00 USD 123,573,997.94 33.856  ...

COPENHAGEN, Denmark--(BUSINESS WIRE)--Keepit, the only independent, cloud-native data protection and recovery provider, proudly announced today that CRN UK—a brand of The Channel Company—has selected Alex Walsh and Cyril VanAgt for inclusion on the prestigious 2026 CRN® Channel Leaders EMEA list. This annual recognition celebrates IT vendor and distribution executives who are shaping channel strategy and driving innovation and partnership across the industry. Keepit operates a 100 percent chann...

TOKYO--(BUSINESS WIRE)--The East Japan Railway Foundation for Cultural Innovation announces the opening of MoN Takanawa: The Museum of Narratives on March 28, 2026. Located within TAKANAWA GATEWAY CITY near Shinagawa Station—a major transportation hub with direct railway access to Haneda and Narita airports—MoN Takanawa is a new cultural hub featuring a striking exterior designed by KENGO KUMA & ASSOCIATES. As an “Experimental Museum,” MoN Takanawa presents cross-disciplinary programs spann...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100 Moderate Buffer UCITS ETF - September 26.03.2026 QSEP.LN IE000FQ808R5 450,002.00 USD 9,995,234.93 22.212  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - May 26.03.2026 GMAY.LN IE000P0FL8E3 900,002.00 USD 34,151,326.30 37.946  ...

北京--(BUSINESS WIRE)--（ビジネスワイヤ） -- バイオサイトジェン （バイオサイトジェン、上海証券取引所：688796、香港証券取引所：02315）は、革新的な技術で新規抗体医薬品の研究開発を推進するバイオテクノロジー企業です。同社はこのたび、パートナーであるNEOK Bio, Inc.が、固形腫瘍を対象とするEGFR/MUC1標的ADCプログラムNEOK002について、米国食品医薬品局（FDA）から治験薬（IND）申請の承認を取得したことを発表しました。NEOK Bioは2026年第2四半期に第1相臨床試験を開始し、2027年に初期データを報告する予定です。 今回のIND承認は、NEOK Bioが開発し、バイオサイトジェンが開発した二重特異性抗体をベースに2024年にライセンス供与されたEGFR/MUC1標的ADC候補であるNEOK002にとって重要なマイルストーンとなります。NEOK Bioによると、NEOK002は固形腫瘍を対象に開発が進められており、いずれか単一の標的に対する単一特異性ADCアプローチと比較して、差別化された有効性と安全性を提供できる可能性...